Cover Image
市场调查报告书

成人呼吸窘迫症候群:全球临床实验趋势

Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品编码 226833
出版日期 内容信息 英文 44 Pages
订单完成后即时交付
价格
Back to Top
成人呼吸窘迫症候群:全球临床实验趋势 Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017
出版日期: 2017年03月15日 内容信息: 英文 44 Pages
简介

本报告提供全球各国成人呼吸窘迫症候群的临床试验相关调查,提供您各地区、进展状况、各期、各募集情况的实验量,加上代表性赞助商,正在开发的治疗药信息,各企业机关的进行状况等信息。

本报告概要

各地区的临床实验情形

  • 各国临床实验数量和平均实验人数
    • 亚太地区主要国家的临床实验数量
    • 欧洲主要5国的临床实验数量
    • 北美主要国家的临床实验数量
    • 中东·非洲主要国家的临床实验数量

G7各国临床实验数量:呼吸系统疾病治疗药临床实验上成人呼吸窘迫症候群的比例

G7各国的各阶段临床实验数量

G7各国临床实验数量:各进展状况

各阶段临床实验数量

  • 进行中的临床实验:各阶段

各进展状况临床实验数量

临床实验的目标达成情形

一定期间所采用的实验对像

赞助商类别的临床实验数量

有潜力的赞助商

成人呼吸窘迫症候群治疗药临床实验主要的参与企业

有潜力的药剂

临床实验简介概要

附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

GlobalData's clinical trial report, "Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017" provides an overview of Adult Respiratory Distress Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Adult Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Clinical Trials by G7 Countries: Proportion of Adult Respiratory Distress Syndrome to Respiratory Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by Phase 17
  • In Progress Trials by Phase 18
  • Clinical Trials by Trial Status 19
  • Clinical Trials by End Point Status 20
  • Subjects Recruited Over a Period of Time 21
  • Clinical Trials by Sponsor Type 22
  • Prominent Sponsors 23
  • Top Companies Participating in Adult Respiratory Distress Syndrome Therapeutics Clinical Trials 24
  • Prominent Drugs 25
  • Clinical Trial Profile Snapshots 26

Appendix 41

  • Abbreviations 41
  • Definitions 41
  • Research Methodology 42
  • Secondary Research 42
  • About GlobalData 43
  • Contact Us 43
  • Source 44

List of Tables

List of Tables

  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Proportion of Adult Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2017* 14
  • Adult Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Adult Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase, 2017* 17
  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 18
  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21
  • Adult Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 22
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25

List of Figures

List of Figures

  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
  • Proportion of Adult Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2017* 14
  • Adult Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Adult Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2017* 17
  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 18
  • Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21
  • Adult Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 22
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
  • Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25
  • GlobalData Methodology 42
Back to Top